Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial

por Zhu, Feng-Cai, Li, Chang-Gui, Pan, Hong-Xing, Zhang, Yi-Ju, Bi, Dan, Tang, Hai-Wen, Datta, Sanjoy
Publicado 2011